Research & Development

TORONTO – INOVAIT, the pan-Canadian network supported by the Government of Canada’s Strategic Innovation Fund, is pleased to announce additional recipients of its Pilot Fund. This competitive funding was awarded to further image-guided therapy (IGT) projects, including the integration of artificial intelligence (AI) and big data analytics to advance medical innovation. Read More

MONTREAL – SCALE AI has announced funding of $50 million for 12 projects. The projects include an AI partnership involving the Centre hospitalier de l’Université de Montréal (CHUM) and Logibec, a growing healthcare software developer based in Quebec. Read More

TORONTO – The GenWell Project – in partnership with Simon Fraser University, the Institute for Social Connection, the Public Health Agency of Canada and several researchers from Canadian Universities – has received $761,000 in Federal funding from the Canadian Institute for Health Research. The funding is to research and produce Canadian Social Connection Guidelines that will help Canadians build a better understanding of the impact of social ties to their health and wellbeing, and its impact on building a healthier society. Read More

LONDON, Ont. – Doctors at Children’s Hospital are testing whether virtual reality can keep childhood cancer patients calm at appointments, a potential pain management strategy that could be used for other illnesses and injuries in kids. The team from Lawson Health Research Institute, the medical research arm of London’s hospitals, is recruiting 90 pediatric cancer patients, ages five to 18, for the virtual reality study that will gauge whether the technology can quell anxiety during medical procedures. Read More

MONTREAL – The federal minister of health, the Honourable Jean-Yves Duclos, has announced an investment of $10 million to create a pan-Canadian platform to advance research into the effectiveness and clinical challenges of new COVID-19 treatments in non-hospitalized patients. Read More

VANCOUVER – Genomic research is leading to incredible advances in modern-day healthcare but combining health and genomic data can greatly accelerate new discoveries. To enable the advancement of medical research and patient care, Genome British Columbia (Genome BC) has committed up to $1 million in partnership with Providence Health Care Ventures (Ventures). Read More

TORONTO – The Ontario Brain Institute (OBI) is pleased to announce the inaugural NERVE cohort, a group of seven entrepreneurs funded through Canada’s single largest award for early-stage neurotechnology development. Formerly known as the Ontario Neurotech Entrepreneurship (ONtrepreneurs) program, the NERVE Program (Neurotech Entrepreneurship to Validate Emerging Innovations) provides $100,000 in funding to each of the Canadian-based entrepreneurs. Read More

VANCOUVER – Taking innovative research from concept to application is critical for improving healthcare systems and the well-being of patients. The Vancouver Coastal Health Research Institute is proud to support investigators and their ground-breaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities. Read More

KITCHENER, Ont. – The Ontario Ministry of Health announced it will invest $1 million in a study at Grand River Hospital to evaluate the use of an intraoperative surgical technology that could improve outcomes for patients who require hip replacement surgery. The study will inform the development of a new pathway to improve the adoption of new medical innovations that will innovate patient care in hospitals across the province. Read More

MONTREAL – The Research Institute of the McGill University Health Centre (RI-MUHC), the McGill University Health Centre (MUHC) Foundation with Boehringer Ingelheim (Canada) Ltd., HOP Tech, and MEDTEQ+ are proud to announce a new, three-year partnership to research and develop artificial intelligence-based technology to better screen for and identify type 2 diabetes mellitus (T2DM) in people 35 and up with cardiovascular risk factors, such as high blood pressure and heart disease. Read More